Company Intelligence Profile

Alde Medi Impex Limited

ALDE MEDI IMPEX LIMITED is a New Delhi pharmaceutical and nutraceutical manufacturer and marketer, founded in 1997 and flagship company of the Alde Group.

CIN: U24231DL1997PLC085614ActiveRoC-Delhi

Last updated 28 October 2026

AI OverviewGenerated from public records

ALDE MEDI IMPEX LIMITED is a New Delhi pharmaceutical and nutraceutical manufacturer and marketer, and the flagship company of the Alde Group. It was incorporated on 05 March 1997 and is an unlisted public company registered with RoC-Delhi. Revenue for FY2023-24 was ₹60.8 Cr. The company has charges registered with ICICI Bank Limited, Axis Bank Limited and Bank of India.

AI-generated summary from public filings and may contain errors. Verify against the detailed sections below.

See what AICA knows about Alde Medi Impex

Deeper analysis, financial signals and peer comparisons.

Book a demo

Company Identity

Registered nameALDE MEDI IMPEX LIMITED
CINU24231DL1997PLC085614
PANAABCA3529J
StatusActive
ListingUnlisted
Incorporated05 March 1997
ROCRoC-Delhi
Sector (NIC)Pharma & Life Sciences (NIC 24231)
Registered addressUnit No-1076, 10th Floor, Agarwal Millennium Tower-II, Netaji Subhash Place, Wazir Pur, New Delhi, Delhi, India, 110034
Authorized capital₹6.00 Cr
Paid-up capital₹4.17 Cr / ₹41,676,000

Business Overview

  • ALDE MEDI IMPEX LIMITED makes and markets pharmaceutical and nutraceutical products across India.
  • Its range covers cardiology, critical care, dermatology, gastroenterology, gynaecology, neurology, orthopaedic, paediatrics and anti-infective therapy areas.
  • The company was founded in 1997 by Rajesh Kumar Rastogi and is based in New Delhi.
  • Its manufacturing facilities are WHO-GMP/GLP and ISO certified.

Directors

NameDINRoleAppointed
Rajesh Kumar Rastogi00340635Chairman & Founder-
Manas Rastogi06958305Director-
Mehul Rastogi06958331Director-

GST Registration

GSTINStatePANStatus
09AABCA3529J1ZOUttar PradeshAABCA3529J-
23AABCA3529J1ZYMadhya PradeshAABCA3529J-

Financials

FY2023-24
  • Revenue ₹60.8 Cr

Charges & Borrowings

ICICI Bank Limited₹20.3 Cr (2 charges)
Axis Bank Limited₹1.1 Cr (1 charge)
Bank of India₹0.3 Cr (3 charges)

Competitors

Alkem Laboratories
large listed Indian pharma company
Mankind Pharma
large listed Indian pharma company
Micro Labs
large private Indian pharma company
Unichem Laboratories
listed Indian pharma company
Corona Remedies
mid-size private pharma company
Systopic Laboratories
mid-size private pharma company

Frequently Asked Questions

What does ALDE MEDI IMPEX LIMITED do?
ALDE MEDI IMPEX LIMITED makes and markets pharmaceutical and nutraceutical products in India. Its therapy areas include cardiology, dermatology, neurology, paediatrics and anti-infective care.
Who are the directors of ALDE MEDI IMPEX LIMITED?
The directors are Rajesh Kumar Rastogi (Chairman and founder), Manas Rastogi and Mehul Rastogi.
When was ALDE MEDI IMPEX LIMITED incorporated?
ALDE MEDI IMPEX LIMITED was incorporated on 05 March 1997 as an unlisted public company.
What is the CIN of ALDE MEDI IMPEX LIMITED?
The CIN of ALDE MEDI IMPEX LIMITED is U24231DL1997PLC085614.
Where is ALDE MEDI IMPEX LIMITED registered?
The registered office is at Unit No-1076, 10th Floor, Agarwal Millennium Tower-II, Netaji Subhash Place, Wazir Pur, New Delhi, Delhi 110034. The company is registered with RoC-Delhi.

Recur Market

Which lenders fit a company like Alde Medi Impex Limited?

Answer a few questions about your business and see which banks and NBFCs match, with indicative rates.

Similar Pharma & Life Sciences companies

More on Recur Club

Explore on Recur Club

More from Recur Club

Looking for business funding?

Recur Club is India's largest AI-native debt platform - working capital, term loans and structured debt from 150+ lending partners, without diluting equity.

Disclaimer: Company information shown on this page is compiled from public records and third-party sources. It may be incomplete, outdated, or contain inaccuracies, and is provided for general informational purposes only. Please verify details independently before relying on them.